stroitelrb.ru


MARINUS STOCK PRICE

Marinus Pharmaceuticals Inc. historical stock charts and prices, analyst ratings, financials, and today's real-time MRNS stock price. Marinus Pharmaceuticals, Inc. (stroitelrb.ru): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Marinus Pharmaceuticals. See the latest Marinus Pharmaceuticals Inc stock price (MRNS:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Price Performance ; 1-Month. +%. on 02/20/ Period Open: %. on 02/09/ (%). since 01/29/24 ; 3-Month. +%. on. View the MRNS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Marinus Pharmaceuticals.

View Marinus Pharmaceuticals, Inc MRNS investment & stock information. Get the latest Marinus Pharmaceuticals, Inc MRNS detailed stock quotes, stock data. The average one-year price target for Marinus Pharmaceuticals, Inc. is $ The forecasts range from a low of $ to a high of $ A stock's price. Get Marinus Pharmaceuticals Inc (MRNS:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. The 8 analysts with month price forecasts for MRNS stock have an average target of , with a low estimate of and a high estimate of The average. Marinus Pharmaceuticals traded at $ this Monday March 11th, decreasing $ or percent since the previous trading session. Stock analysis for Marinus Pharmaceuticals Inc (MRNS:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company. Marinus Pharmaceuticals Inc. MRNS (U.S.: Nasdaq). AT CLOSE PM EDT 03/12/ $USD; %. Volume, AFTER HOURS PM EDT 03/12/ (NASDAQ: MRNS) Marinus Pharmaceuticals stock price per share is $ today (as of Mar 11, ). What is Marinus Pharmaceuticals's Market Cap. Looking to buy Marinus Pharmaceuticals Stock? View today's MRNS stock price, trade commission-free, and discuss MRNS stock updates with the investor. The mean of analysts' price targets for Marinus Pharmaceuticals (MRNS) points to an % upside in the stock. While this highly sought-after metric has not. Marinus Pharmaceuticals, Inc. Common Stock (MRNS) · Quotes · NEWS & ANALYSIS.

Marinus Pharmaceuticals Inc. (MRNS) Stock Performance ; Marinus Pharmaceuticals (MRNS). , ; S&P BSE Sensex · , ; S&P Small-Cap · , -. Find the latest Marinus Pharmaceuticals, Inc. (MRNS) stock quote, history, news and other vital information to help you with your stock trading and. Marinus Pharmaceuticals, Inc. Common Stock (MRNS) · Bid Price and Ask Price. MRNS Stock Performance ; Previous close, ; Day range, - ; Year range, 5 - 11 ; Market cap, ,, Marinus Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the identification and development of neuropsychiatric therapeutics. DiaMedica Therapeutics Names Lorianne Masuoka as Chief Medical Officer · Marinus Pharmaceuticals Raises Product Revenue Expectation · RBC Raises Price Target. Those who invested in Marinus Pharmaceuticals (NASDAQ:MRNS) a year ago are up %. The most you can lose on any stock (assuming you don't use leverage) is Stock Price Target. High, $ Low, $ Average, $ Current Price, $ MRNS will report FY earnings on 03/05/ Yearly Estimates. Previous close. The last closing price. $ ; Day range. The range between the high and low prices over the past day. $ - $ ; Year range. The range.

The last closing price for Marinus Pharmaceuticals was $ Over the last year, Marinus Pharmaceuticals shares have traded in a share price range of $ Based on 10 Wall Street analysts offering 12 month price targets for Marinus in the last 3 months. The average price target is $ with a high forecast of. Analyst's Opinion · Consensus Rating. Marinus Pharmaceuticals has received a consensus rating of Moderate Buy. · Price Target Upside/Downside. According to. Does Marinus Pharmaceuticals (NASDAQ:MRNS) Have A Healthy Balance Sheet? Marinus Pharmaceuticals, Inc. Announces Seven Presentations at AES , New. (NASDAQ: MRNS) Marinus Pharmaceuticals stock price per share is $ today (as of Mar 11, ). What is Marinus Pharmaceuticals's Market Cap.

Marinus Pharmaceuticals, Inc. (stroitelrb.ru): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Marinus Pharmaceuticals. In depth view into MRNS (Marinus Pharmaceuticals) stock including the latest price, news, dividend history, earnings information and financials. Analyst's Opinion · Consensus Rating. Marinus Pharmaceuticals has received a consensus rating of Moderate Buy. · Price Target Upside/Downside. According to. Why Marinus Pharmaceuticals Stock Skyrocketed 80% Higher Today. Investors are thrilled with the results from a late-stage clinical study of the company's only. Get the latest Marinus Pharmaceuticals Inc. (MRNS) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. Currency, USD ; Margin, 20% ; Stock exchange, United States of America ; Commission on trade, 0% ; Prev. Close*, All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at.

buying airline tickets as a gift | top 5 cryptocurrency to invest in 2021

19 20 21 22 23

Copyright 2015-2024 Privice Policy Contacts SiteMap RSS